Sfoglia per Autore  IANZA, ANNA

Opzioni
Mostrati risultati da 1 a 14 di 14
Titolo Data di pubblicazione Autori File
Erratum to: Advances in systemic therapy for metastatic breast cancer: future perspectives (Medical Oncology, (2017), 34, 7, (119), 10.1007/s12032-017-0975-5) 1-gen-2017 Sobhani, N.Ianza, A.Roviello, G.Mustacchi, G.Bortul, M.Zanconati, F.Generali, D. +
Need for randomized clinical trials testing targeted therapies in malignant pleural mesothelioma 1-gen-2017 SOBHANI, NAVIDROVIELLO, GIANDOMENICOCorona, S. P.IANZA, ANNAZANCONATI, FABRIZIOGENERALI, DANIELE
Advances in systemic therapy for metastatic breast cancer: future perspectives 1-gen-2017 Corona, S. P.SOBHANI, NAVIDIANZA, ANNAROVIELLO, GIANDOMENICOMUSTACCHI, GIORGIOBORTUL, MARINAZANCONATI, FABRIZIOGENERALI, DANIELE
Advances in systemic therapy for malignant mesothelioma: Future perspectives 1-gen-2017 Sobhani, NavidCorona, Silvia PaolaBonazza, DeborahIanza, AnnaRoviello, GiandomenicoCortale, MaurizioGuglielmi, AlessandraZanconati, FabrizioGenerali, Daniele +
Current Status of Fibroblast Growth Factor Receptor-Targeted Therapies in Breast Cancer 1-gen-2018 Sobhani, NavidIanza, AnnaRoviello, GiandomenicoGiudici, FabiolaBortul, MarinaZanconati, FabrizioBottin, CristinaGenerali, Daniele +
Lenvatinib for the treatment of renal cell carcinoma 1-gen-2018 Roviello G.Corona S.Generali D.Ianza A.Sobhani N. +
The prognostic value of PI3K mutational status in breast cancer: A meta-analysis 1-gen-2018 Sobhani, NavidRoviello, GiandomenicoCORONA, SILVIAIanza, AnnaBortul, MarinaZanconati, FabrizioGenerali, Daniele +
Tumour infiltrating lymphocytes and PD-L1 expression as potential predictors of outcome in patients with malignant pleural mesothelioma 1-gen-2019 Sobhani NRoviello GIanza ABonazza DZanconati FGiudici FBottin CCorona SPRizzardi CCortale MConfalonieri MGenerali D. +
Optimal primary end point in Phase II trials of immune checkpoint inhibitors for advanced solid cancers: An evolving issue 1-gen-2019 Roviello G.Generali D.Ianza A.
ΔKi67 proliferation index as independent predictive and prognostic factor of outcome in luminal breast cancer: data from neoadjuvant letrozole-based treatment 1-gen-2020 Ianza A.Giudici F.Bernocchi O.Bortul M.Allevi G.Cappelletti M.Generali D. +
Immune system and angiogenesis-related potential surrogate biomarkers of response to everolimus-based treatment in hormone receptor-positive breast cancer: an exploratory study 1-gen-2020 Sobhani, NavidIanza, AnnaBernocchi, OttaviaGiudici, FabiolaGenerali, Daniele +
VALIDATION OF PREDICTIVE AND PROGNOSTIC BIOMARKERS AS A GUIDE FOR A PERSONALIZED APPROACH IN SOLID TUMOURS 22-ott-2020 IANZA, ANNA
Role of the IGF-1 Axis in Overcoming Resistance in Breast Cancer 1-gen-2021 Ianza A.Bernocchi O.Generali D. +
EGFR mutation analysis on circulating free DNA in NSCLC: a single-center experience 1-gen-2021 Ianza, AnnaDi Chicco, A.Giudici, F.Roviello, G.Generali, D.Zanconati, F. +
Mostrati risultati da 1 a 14 di 14
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile